Caroline Erickson

University of California, San Francisco — United States

Medicine · Health Sciences

12h-index1.1kcitations26works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Myeloid Leukemia Research(7), RNA Research and Splicing(6), Immune Cell Function and Interaction(5), RNA modifications and cancer(5), RNA Interference and Gene Delivery(4)

Publications26 total

Addressing Colorectal Cancer Disparities in Unhoused Populations: A Call for Equitable Access and Compassionate Care
Clinics in Colon and Rectal Surgery·2024· 1 citedOpen Access
Systematic evaluation of AML-associated antigens identifies anti-U5 SNRNP200 therapeutic antibodies for the treatment of acute myeloid leukemia
Nature Cancer·2023· 21 citedOpen Access
Data from Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation
2023Open Access
Abstract 5742: Pharmacologic modulation of RNA splicing enhances anti-tumor immunity
Cancer Research·2023· 1 cited
Supplementary Figure from Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation
2023Open Access
Data from Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation
2023Open Access
Supplementary Figure from Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation
2023Open Access
Modulation of RNA splicing enhances response to BCL2 inhibition in leukemia
Cancer Cell·2022· 74 citedOpen Access
RAF-Independent MEK Mutations Drive Histiocytic Neoplasms <i>In Vivo</i> and Are Sensitive to Single-Agent ERK Inhibition in Patients
Blood·2022· 1 cited
Systematic Evaluation of AML-Associated Antigens Identifies Novel Anti-U5 snRNP200 Therapeutic Antibodies for the Treatment of AML
Blood·2022
Attenuation of Graft-Versus-Host-Disease Via Genetic or Pharmacologic Inhibition of the RNA Splicing Factor RBM39
Blood·2022· 1 cited
Medical Certification for Utility Shut-Off Protection and Health-Related Social Needs
PEDIATRICS·2022· 5 citedOpen Access
Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation
Cancer Discovery·2022· 36 citedOpen Access
Synthetic introns enable splicing factor mutation-dependent targeting of cancer cells
Nature Biotechnology·2022· 59 citedOpen Access
Impaired RAS Proteolysis Drives Clonal Hematopoietic Transformation
Blood·2021
Modulation of RNA Splicing Enhances Response to BCL2 Inhibition in Acute Myeloid Leukemia
Blood·2021· 2 cited
Developing human pluripotent stem cell-based cerebral organoids with a controllable microglia ratio for modeling brain development and pathology
Stem Cell Reports·2021· 204 citedOpen Access
Pharmacologic modulation of RNA splicing enhances anti-tumor immunity
Cell·2021· 268 citedOpen Access
Minor intron retention drives clonal hematopoietic disorders and diverse cancer predisposition
Nature Genetics·2021· 105 citedOpen Access
<i>ZRSR2</i> Mutation Induced Minor Intron Retention Drives MDS and Diverse Cancer Predisposition Via Aberrant Splicing of <i>LZTR1</i>
Blood·2020· 3 cited
page 1 of 2Next →

Frequent Co-authors

Omar Abdel‐Wahab(19), Simon J. Hogg(14), Eric Wang(13), Benjamin H. Durham(13), Michael Singer(12), Katherine Knorr(11), Daichi Inoue(10), Robert Stanley(10), Sydney X. Lu(8), Pau Castel(8), Frank McCormick(8), Salima Benbarche(8), Bin Lü(7), Robert K. Bradley(7), Justin Taylor(7), Won Jun Kim(7), Steven Tittley(7), Neal Rosen(7), Michael F. Walsh(6), Rahul S. Vedula(6)